Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Selvedge Venture invests in startups targeting age-related medical conditions, specifically Metabolic Syndrome, Cancer, and Neurodegenerative Diseases. The firm participates in Pre-Seed, Seed, and Series A funding rounds, utilizing advancements in biotechnology and digital technologies to enhance healthcare outcomes.
Notable portfolio companies include Kytopen, an MIT spin-out focused on engineered cell therapies; Sanome, which develops a human digital twin for early health change detection; and Yuri, providing services for research and commercial applications in microgravity.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.